Critical Reviews in Oncology / Hematology
Volume 77, Issue 2 , Pages 109-130, February 2011

Employment and work-related issues in cancer survivors

  • Anja Mehnert

      Affiliations

    • Corresponding Author InformationTel.: +49 40 7410 56203; fax: +49 40 7410 54940.

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52–W26, 20246 Hamburg, Germany

Accepted 6 January 2010. published online 01 February 2010.

Abstract 

Purpose of this systematic literature review was to identify current knowledge about employment in cancer survivors. Sixty-four studies met inclusion criteria that were original papers published between 01/2000 and 11/2009. Overall, 63.5% of cancer survivors (range 24–94%) returned to work. The mean duration of absence from work was 151 days. Factors significantly associated with a greater likelihood of being employed or return to work were perceived employer accommodation, flexible working arrangements, counseling, training and rehabilitation services, younger age and cancer sites of younger individuals, higher levels of education, male gender, less physical symptoms, lower length of sick leave and continuity of care. Cancer survivors had a significantly increased risk for unemployment, early retirement and were less likely to be re-employed. Between 26% and 53% of cancer survivors lost their job or quit working over a 72-month period post diagnosis. Between 23% and 75% of patients who lost their job were re-employed. A high proportion of patients experienced at least temporary changes in work schedules, work hours, wages and a decline in work ability compared to non-cancer groups.

Keywords: Cancer, Survivorship, Employment, Work, Work ability

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1040-8428(10)00005-3

doi:10.1016/j.critrevonc.2010.01.004

Critical Reviews in Oncology / Hematology
Volume 77, Issue 2 , Pages 109-130, February 2011